Regina Demlova

Introductory word on the development of CZECRIN with a focus on DONets

Irena Doležalová

DONet: EPI

Filip Trbusek

Academic KH at the NÚDZ

Peter Grell

CZECRINonco – RASmiR, GastroPET, GENESIS, EVOLUTION…

Veronika Kunešová

National Ictal Research Network – STROCZECH

Zuzana Motovská

The importance of collaboration and methodological infrastructure for quality academic clinical research

Jiří Deml

Pharmacoeconomics as part of clinical research

Jan Herudek

FGF2-STAB growth factor in chronic wound healing

Michal Kýr

Specific clinical trial designs

Lenka Součková

Clinical Trial Unit Certification (CTU/CTC) Program

Tomas Juren

The POPART study – Prophylactic Oropharyngeal surfactant for Preterm infants: A Randomised Trial

Eva Hlaváčková

Monocentric experience with autologous dendritic cell vaccine

Jan Maláska

Effect of dexamethasone in patients with ARDS and COVID-19 – a prospective, multicenter, open-label, randomized controlled trial with parallel groups

Daniela Žáčková

HALF: Multicentre academic phase II study of tyrosine kinase inhibitors after two-step dose reduction in patients with chronic myeloid leukaemia – results to date

Jacques Demotes

ECRIN | Challenges of new clinical trials designs

Maria Dutarte

EUPATI | Enhancing patient engagement through education

Jon Salmanton Garcia

VACCELERATE | European Corona Vaccine Trial Accelerator Platform

Katerina Nebeska

CONSCIOUS – educational projects in CT